相关实验视频

Updated: May 4, 2026

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

手术植入的Impella微轴流量在心力衰竭相关心脏发生性休克的结果

Jacob Abraham¹, Mark Anderson², Scott Silvestry³

¹Center for Cardiovascular Analytics, Research, & Data Science (CARDS), Providence St. Joseph Research Network, Portland, OR.

Journal of cardiac failure

|March 31, 2025

概括

众所周知的微轴流量 (Impella 5.5) 显示,心力衰竭心脏性休克 (HF-CS) 患者的生存率很好. 这项研究强调了积极的结果,作为通往本土心脏存活或心脏替代疗法的桥梁.

科学领域:

心脏病学心脏病学
机械循环支持机械循环支持
心脏衰竭研究研究

背景情况:

对心脏性休克 (CS) 增加了Impella 5.5的使用.
关于心力衰竭CS (HF-CS) 指示和结果的有限数据.

研究的目的:

描述使用Impella 5.5.5.治疗HF-CS患者的临床特征和结果.
评估HF-CS.中与Impella 5.5相关的生存率和不良事件.

主要方法:

未来的,多中心的观察性研究.
对444名接受Impella 5.5.5.5治疗的高频心血管疾病患者的分析.
对单独使用Impella 5.5和多种临时机械循环支持 (tMCS) 设备进行评估的结果,分为本地心脏存活率 (NHS) 和心脏替代疗法 (HRT) 的分层.

主要成果:

住院生存率:整体75.0%,单独使用Impella 5.5的86.5%,多次tMCS的65.0%.
在多重tMCS组中,替代疗法和血小板狭窄率更高.
6个月和12个月的存活率:NHS为71.3%和64.4%,HRT为>93%.

结论:

在HF-CS患者中,Impella 5.5显示出良好的住院,6个月和12个月的生存期.
作为通往本土心脏存活或心脏替代疗法的桥梁,有效.
支持在精选的高频-CS群体中使用Impella 5.5.

关键词:

心脏发生的冲击是心脏的冲击.心脏衰竭是因为心脏衰竭.机械循环支持机械循环支持

更多相关视频

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device

Published on: July 20, 2022

相关概念视频

Heart Failure VI: Adjunct Therapies

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.

Cardiomyopathy V: Interprofessional Care

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...